The UK NSC requires further supporting evidence before it can recommend SMA screening as a long term addition to the newborn screening programme. The evidence generated by the Scottish ISE will be submitted to the National Institute for Health and Care Research (NIHR), which will analyse it alongside data from the planned SMA ISE in England.